242 related articles for article (PubMed ID: 22826885)
1. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.
Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Löbenberg R
Ther Deliv; 2011 Oct; 2(10):1313-24. PubMed ID: 22826885
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary drug delivery by powder aerosols.
Yang MY; Chan JG; Chan HK
J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
[TBL] [Abstract][Full Text] [Related]
3. Single-use disposable dry powder inhalers for pulmonary drug delivery.
Friebel C; Steckel H
Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
[TBL] [Abstract][Full Text] [Related]
4. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
5. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
6. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
Lin YW; Wong J; Qu L; Chan HK; Zhou QT
Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
[TBL] [Abstract][Full Text] [Related]
7. Inhalable nanoparticulate powders for respiratory delivery.
Muralidharan P; Malapit M; Mallory E; Hayes D; Mansour HM
Nanomedicine; 2015 Jul; 11(5):1189-99. PubMed ID: 25659645
[TBL] [Abstract][Full Text] [Related]
8. Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery.
Shiehzadeh F; Tafaghodi M
Curr Pharm Des; 2016; 22(17):2549-60. PubMed ID: 26818872
[TBL] [Abstract][Full Text] [Related]
9. Novel dry powder inhaler particle-dispersion systems.
Donovan MJ; Gibbons A; Herpin MJ; Marek S; McGill SL; Smyth HD
Ther Deliv; 2011 Oct; 2(10):1295-311. PubMed ID: 22826884
[TBL] [Abstract][Full Text] [Related]
10. How can we bring high drug doses to the lung?
Claus S; Weiler C; Schiewe J; Friess W
Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
[TBL] [Abstract][Full Text] [Related]
11. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
12. The role of disposable inhalers in pulmonary drug delivery.
de Boer AH; Hagedoorn P
Expert Opin Drug Deliv; 2015 Jan; 12(1):143-57. PubMed ID: 25374325
[TBL] [Abstract][Full Text] [Related]
13. A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery.
Pasero L; Susa F; Limongi T; Pisano R
Int J Pharm; 2024 Jun; 659():124248. PubMed ID: 38782150
[TBL] [Abstract][Full Text] [Related]
14. Devices for dry powder drug delivery to the lung.
Berkenfeld K; Lamprecht A; McConville JT
AAPS PharmSciTech; 2015 Jun; 16(3):479-90. PubMed ID: 25964142
[TBL] [Abstract][Full Text] [Related]
15. The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review.
Clark AR
Curr Pharm Des; 2015; 21(27):3974-83. PubMed ID: 26290203
[TBL] [Abstract][Full Text] [Related]
16. Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment.
Bardoliwala D; Javia A; Ghosh S; Misra A; Sawant K
Ther Deliv; 2021 May; 12(5):397-418. PubMed ID: 33902294
[TBL] [Abstract][Full Text] [Related]
17. Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research.
Chan HW; Chow S; Zhang X; Zhao Y; Tong HHY; Chow SF
AAPS PharmSciTech; 2023 Apr; 24(4):98. PubMed ID: 37016029
[TBL] [Abstract][Full Text] [Related]
18. Dry powder inhalation: past, present and future.
de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
[TBL] [Abstract][Full Text] [Related]
19. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder.
Cai X; Yang Y; Xie X; Yu F; Yang Y; Yang Z; Zhang T; Mei X
Drug Deliv; 2016 Jul; 23(6):1962-71. PubMed ID: 26066037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
